Liraglutide in cardiovascular conditions | Patent Number 09968659

US 09968659 B2
Application Number15401651
Publication NumberUS 20170252408 A1
Pendency1 year, 4 months, 6 days
Filled DateJan 9, 2017
Priority DateJan 9, 2017
Publication DateSep 7, 2017
Expiration DateJan 8, 2037
Inventor/ApplicantsKajsa Kvist
Soeren Rasmussen
ExaminesYANG, KAIPEEN E
Art Unit1675
Technology Center1600
Assignments
Novo Nordisk
Current
Novo Nordisk
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.